Business Overview

We primarily engage in researching, developing, manufacturing and selling bamboo charcoal biomass organic fertilizers, amino acid water-soluble fertilizers, selenium-rich foliage fertilizers and other types of fertilizers in the PRC through our subsidiary, Jiangxi Kenongwo Technology Co., Ltd. ("Jiangxi Kenongwo"), a company incorporated under the laws of the PRC.





We generated our revenue from the sales of our organic fertilizers. We currently
have one integrated factory covering a land area of 143,590 square feet in
Yichun City, Jiangxi Province, PRC to produce our organic fertilizers, which has
been in operations since 2017. We plan to expand our production capacity and
build an automatic and standardized production line.



We believe that our brand reputation and ability to tailor our products to meet
the requirements of various regions of the PRC affords us a competitive
advantage. We purchase the majority of our raw materials from suppliers located
in the PRC and use suppliers that are located in close proximity to our
manufacturing facilities, which helps us to control our cost of revenue.



Amidst the COVID-19 outbreak in 2020, our business operations were adversely
impacted. In particular, the lockdown policy in China has caused delays in the
logistics industry and consequently, the supply of our raw materials was
impacted. In addition, the restrictions of face-to-face interactions have slowed
down the process of our marketing, client meeting and new products launching
activities. The spread of COVID-19 has been effectively controlled in China.
People's daily life and businesses' operations started going to normalcy. As a
result, we believe these negative impacts are temporary. However, there is
significant uncertainty around the breadth and duration of business disruptions
related to COVID-19, as well as its impact on the economy of China and the rest
of the world and, as such, the extent of the business disruption and the related
financial impact cannot be reasonably estimated at this time.



China is the principal market for our products, which are primarily sold to our
customers through distributors in over twenty provinces in China, including
Jiangxi, Hunan, Hubei, Fujian, Jiangsu, Shanghai, Zhejiang, Sichuan, Chongqing,
Guangdong, Hainan, Xinjiang, Guizhou, Anhui, Shandong, Shanxi, Shaanxi,
Liaoning, Jilin, Heilongjiang, Yunnan and Guangxi provinces.



Critical Accounting Policies



Management's discussion and analysis of our financial condition and results of
operations are based upon our consolidated financial statements, which have been
prepared in accordance with US GAAP. Our financial statements reflect the
selection and application of accounting policies that require management to make
significant estimates and judgments. We believe the following critical
accounting policies used in the preparation of our financial statements require
significant judgments and estimates. For additional information relating to
these and other accounting policies, see Note 2 to our financial statements
included elsewhere in this report.



Basis of Presentation


Our financial statements are prepared in accordance with generally accepted accounting principles in the United States, or U.S. GAAP.





Going Concern



The accompanying unaudited condensed consolidated financial statements have been
prepared assuming that the Company will continue as a going concern.
The Company has reported a net income of $460,512 for the nine months ended
September 30, 2022. As of September 30, 2022, the Company had an accumulated
deficit of $1,976,445, working capital deficit of $372,583 and net cash used in
operating activities for the nine months ended September 30, 2022 was $514,182.



The Company plans to continue its expansion and investments, which will require continued improvements in revenue, net income, and cash flows.





                                       17





Revenue Recognition



The Company adopted ASC 606 "Revenue Recognition", and recognizes revenue when
control of the promised goods or services is transferred to customers, in an
amount that reflects the consideration we expect to be entitled to in exchange
for those goods or services.



The Company derives its revenues from the sale of fertilizer products. The
Company applies the following five steps in order to determine the appropriate
amount of revenue to be recognized as it fulfils its obligations under each of
its agreements:



  ? identify the contract with a customer;

  ? identify the performance obligations in the contract;

  ? determine the transaction price;

? allocate the transaction price to performance obligations in the contract; and



  ? recognize revenue as the performance obligation is satisfied.




Results of Operations



Comparison of the Three months ended September 30, 2022 and 2021





                                             For the Three months ended
                                                    September 30,                      Variance
                                                2022               2021          Amount            %
                                                  $                 $               $
Revenues                                         1,662,135          69,565       1,592,570       2289.33 %
Cost of revenues                                 1,233,295          54,022       1,179,273       2182.95 %
Gross profit                                       428,840          15,543         413,297       2659.06 %
Operating expenses:
Selling expenses                                    46,503          86,592         (40,089 )      (46.30 )%

General and administrative expenses                151,561         139,884          11,677          8.35 %
Total operating expenses                           198,064         226,476         (28,412 )      (12.55 )%
Income (Loss) from operations                      230,776        (210,933 )       441,709       (209.41 )%
Other income (expense):
Interest expense                                    (7,815 )        (8,292 )           477         (5.75 )%
Other income (expense), net                         (9,940 )        (2,458 )        (7,482 )      304.39 %
Total other (expense) income                       (17,755 )       (10,750 )        (7,005 )       65.16 %
Income (Loss) before income taxes                  213,021        (221,683

)       434,704       (196.09 )%
Income taxes                                             -               -               -             -
Net income (loss)                                  213,021        (221,683 )       434,704       (196.09 )%




Revenue



For the three months ended September 30, 2022, our total revenue was $1.66
million, representing an increase of 2289.33% compared to $0.07 million for the
same period in 2021. This increase was mainly due to an increase in demand of
our products after the Company developed and obtained more customers.



                                       18




The Company's disaggregate revenue streams are summarized as follows:





                                          For the Three months ended
                                                 September 30,
                                              2022               2021

Revenues - Solid organic fertilizers $ 1,662,135 $ 35,404 Revenues - Liquid organic fertilizers

                  -         34,161
Total revenues                          $      1,662,135       $ 69,565




Cost of revenues



Cost of revenues for the fertilizers was $1.23 million and $0.05 million for the
three months ended September 30, 2022 and 2021, respectively, representing an
increase of 2182.95%. The increase in cost of revenues was in line with an
increase in revenue.



The Company's disaggregate cost of revenues streams are summarized as follows:



                                                                    For the Three months ended
                                                                          September 30,
                                                                       2022               2021
Cost of revenues - Bamboo charcoal biomass organic fertilizers   $      1,233,295       $  25,818
Cost of revenues - Others                                                       -          28,204
Total cost of revenues                                           $      1,233,295       $  54,022




Gross Profit



Our gross profit was $0.43 million and $0.02 million with gross margin of 25.80%
and 22.34%, for the three months ended September 30, 2022 and 2021,
respectively. The gross margin increased because the revenue increased 2289.33%
while the cost of revenue increased 2182.95% for the three months ended
September 30, 2022 compared to the same period in 2021.



Selling Expenses



Our selling expenses were $46,503 for the three months ended September 30, 2022,
representing a decrease of $40,089 or 46.30% compared to $86,592 for the three
months ended September 30, 2021. It was mainly the Company controls costs,
reduces travel expenses, advertising expenses, etc.



General and Administrative Expenses





General and administrative expenses increased by $11,677, or 8.35% from $139,884
for the three months ended September 30, 2021 to $151,561 for the same period in
2022 due to the fact that salary increased.



                                       19




Research and Development ("R&D") Expenses





Research and development expenses include salaries and other
compensation-related expenses paid to the Company's research and product
development personnel while they are working on R&D projects, as well as raw
materials used for the R&D projects. R&D expenses incurred by the Company are
included in the general and administrative expenses and totaled $75,387 and
$42,538 for the three months ended September 30, 2022 and 2021, respectively.



Net Income/(Loss)



Our net income (loss) was $213,021 and ($221,683) for the three months ended
September 30, 2022 and 2021, respectively, representing an increase of $434,704.
The Company is at its developing stage and we have incurred more promotion fee
by introducing our products to more customers across China during the three
months ended September 31, 2021 resulting in significant increase in revenue for
the three months ended September 30, 2022. The Company also incurred more
material cost by developing new product lines. The Company expects that more
time is needed to achieve a better balance between our operating expenses and
revenues.


Comparison of the Nine months ended September 30, 2022 and 2021





                                             For the Nine months ended
                                                   September 30,                      Variance
                                                2022              2021          Amount            %
                                                 $                 $               $
Revenues                                        5,210,549         349,259       4,861,290       1391.89 %
Cost of revenues                                3,965,173         517,826       3,447,347        665.73 %
Gross profit (loss)                             1,245,376        (168,567 )     1,413,943       (838.80 )%
Operating expenses:
Selling expenses                                  165,306         215,984         (50,678 )      (23.46 )%
General and administrative expenses               495,378         263,670         231,708         87.88 %
Total operating expenses                          660,684         479,654         181,030         37.74 %
Loss from operations                              584,692        (648,221 )     1,232,913       (190.20 )%
Other income (expense):
Interest expense                                  (24,177 )       (21,406 )        (2,771 )       12.94 %
Other (expense) income, net                      (100,003 )        11,764        (111,767 )     (950.08 )%
Total other income                               (124,180 )        (9,642 )      (114,538 )     1187.91 %
Loss before income taxes                          460,512        (657,863 )     1,118,375       (170.00 )%
Income taxes                                            -               -               -             -
Net income (loss)                                 460,512        (657,863 )

    1,118,375       (170.00 )%




Revenue



For the nine months ended September 30, 2022, our total revenue was $5.21
million, representing an increase of 1391.89% compared to $0.35 million for the
same period in 2021. This increase was mainly due to an increase in demand of
our products after the Company developed and obtained more customers.



The Company's disaggregate revenue streams are summarized as follows:





                                          For the Nine months ended
                                                September 30,
                                             2022              2021

Revenues - Solid organic fertilizers $ 5,210,549 $ 278,251 Revenues - Liquid organic fertilizers

                 -         71,008
Total revenues                          $     5,210,549      $ 349,259




                                       20





Cost of revenues



Cost of revenues for the fertilizers was $3.97 million and $0.52 million for the
nine months ended September 30, 2022 and 2021, respectively, representing an
increase of 665.73%. The increase in cost of revenues was in line with an
increase in revenue.



The Company's disaggregate cost of revenues streams are summarized as follows:



                                                  For the Nine months ended
                                                        September 30,
                                                     2022              2021

Cost of revenues - Solid organic fertilizers $ 3,965,173 $ 415,749 Cost of revenues - Liquid organic fertilizers

                 -        102,077
Total cost of revenues                          $     3,965,173      $ 517,826




Gross Profit (Loss)



Our gross profit (loss) was $1.25 million and negative ($0.17) million with
gross margin of 23.90% and (48.26%),  for the nine months ended September 30,
2022 and 2021, respectively. The negative gross margin improved because the
revenue increased 1391.89% while the cost of revenue increased 665.73% for the
nine months ended September 30, 2022 compared to the same period in 2021.



Selling Expenses



Our selling expenses were $165,306 for the nine months ended September 30, 2022,
representing a decrease of $50,678 or 23.46% compared to $215,984 for the nine
months ended September 30, 2021. It was mainly the Company controls costs,
reduces travel expenses, advertising expenses, etc.



General and Administrative Expenses

General and administrative expenses increased by $231,708, or 87.88% from $263,670 for the nine months ended September 30, 2021 to $495,378 for the same period in 2022 due to increased salaries.

Research and Development ("R&D") Expenses





Research and development expenses include salaries and other
compensation-related expenses paid to the Company's research and product
development personnel while they are working on R&D projects, as well as raw
materials used for the R&D projects. R&D expenses incurred by the Company are
included in the general and administrative expenses and totaled $116,342 and
$52,856 for the nine months ended September 30, 2022 and 2021, respectively.



Net Income (Loss)



Our net income (loss) was $460,512 and ($657,863) for the nine months ended
September 30, 2022 and 2021, respectively, representing an increase of
$1,118,375. The Company is at its developing stage and we have incurred more
promotion fee by introducing our products to more customers across China during
the nine months ended September 30, 2021 resulting in significant increase in
revenue for the nine months ended September 30, 2022. The Company also incurred
more material cost by developing new product lines. The Company expects that
more time is needed to achieve a better balance between our operating expenses
and revenues.


Liquidity and Capital Resources

Our working capital deficit was $372,583 and $3,760,370 as of September 30, 2022 and December 31, 2021, respectively.

We have financed our operations over the nine months ended September 30, 2022 and 2021 primarily through proceeds from advances from related parties.





                                       21




The components of cash flows are discussed below:





                                              For the Nine months ended
                                                    September 30,
                                                2022              2021

Net cash used in operating activities $ (514,182 ) $ (764,741 ) Net cash used in investing activities

             (39,157 )       (463,008 )
Net cash provided by financing activities         588,736        1,232,933
Exchange rate effect on cash                      (39,120 )         (6,337 )
Net cash inflow                             $      (3,723 )    $    (1,153 )

Cash used in Operating Activities





For the nine months ended September 30, 2022, net cash used in operating
activities was $514,182, which consisted primarily of net income of $460,512,
which was adjusted by depreciation and amortization of $103,869. The Company had
an increase of $36,834 in account payables and accrued payables in which it was
due to the Company purchased more raw materials and pay off the bills in longer
terms, an  increase of $1,120,167 in accounts receivable which was due to the
Company increase of revenue, a  decrease of $112,931 in prepayments to the
suppliers for procurement of raw materials and deposit for the building
materials and equipment, which were offset by an increase of $66,097 in
inventories and an increase in other receivable of $42,461 in which it was due
to an increase loan receivables.



For the nine months ended September 30, 2021, net cash used in operating
activities was $764,741, which consisted primarily of net loss of $657,863,
which was adjusted by depreciation and amortization of $40,899. The Company had
an increase of $370,068 in account payables and accrued payables in which it was
due to the Company purchased more raw materials and pay off the bills in longer
terms, an increase of $10,798 in accounts receivable which was due to longer
payment terms were offered to loyal customers , an increase of $190,971 in
prepayments to the suppliers for procurement of raw materials and deposit for
the building materials and equipment, and an increase of $306,913 in inventories
and an increase in other receivable of $12,693 in which it was due to an
increase loan receivables.



Cash used in Investing Activities


Net cash used in investing activities was $39,157 for the nine months ended
September 30, 2022. The activities consisted of our investments of $38,806 in
purchasing plant and equipment and an adjustment of $1,713 of intangible assets
due to currency exchange effect, and an increase in disposal of equipment of
$1,362.



Net cash used in investing activities was $463,008 for the nine months ended
September 30, 2021. The activities consisted of our investments of $461,942 in
purchasing plant and equipment and an adjustment of $1,066 of intangible assets
due to currency exchange effect.



Cash Provided by Financing Activities


Net cash provided by financing activities was $588,736 for the nine months ended
September 30, 2022. During this period, cash provided by financing activities
mainly included proceeds from related parties of $588,736.



Net cash provided by financing activities was $1,232,933 for the nine months ended September 30, 2021. During this period, cash provided by financing activities mainly included proceeds from related parties of $800,126 and proceeds from long-term loan of $432,807 for operating expenses.

Off-balance Sheet Arrangements





We have not entered into any financial guarantees or other commitments to
guarantee the payment obligations of any third parties. We have not entered into
any derivative contracts that are indexed to its shares and classified as
shareholder's equity or that are not reflected in its consolidated financial
statements. Furthermore, we do not have any retained or contingent interest in
assets transferred to an unconsolidated entity that serves as credit, liquidity
or market risk support to such entity. We do not have any variable interest in
any unconsolidated entity that provides financing, liquidity, market risk or
credit support to us or that engages in leasing, hedging or research and
development services with us.



                                       22

© Edgar Online, source Glimpses